Sign inJoin waitlistJoin the waitlist

Chaitra Ujjani

Professor, Clinical Research Division, Fred Hutch · University of Washington School of Medicine

Credentials: · · · · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

MedStar Georgetown University Hospital
2008–2011
Internal Medicine
2005–2008
University of Alabama at Birmingham Marnix E. Heersink School of Medicine
2001–2005

Research

Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis
Haematologica · 2018 · Last of 26 authors · 406 citations
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Blood · 2020 · 267 citations
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
Nature Medicine · 2022 · 261 citations

Mazyar Shadman
50 papers
Ajay Gopal
29 papers
Ryan Lynch
28 papers
Stephen Smith
27 papers
BC
Bruce Cheson
26 papers
Anthony Mato
24 papers · 1 as a fellow
Stephen Schuster
23 papers
Brian Till
22 papers
Nicole Lamanna
22 papers
Alan Skarbnik
21 papers
Brian Hill
20 papers
Lindsey Roeker
18 papers · 12 as a fellow

Clinical trials

Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Principal investigator · Terminated
University of Washington
2021–2024
Phase I Study of Lenalidomide, Rituximab and Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Principal investigator · Terminated · Phase 1
Georgetown University
2014–2017
Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
2013–2027
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Study chair · Completed · Phase 1, Phase 2
Georgetown University
2017–2024